Neuroinflammation — the activation of microglia (the brain's immune cells) and the production of pro-inflammatory cytokines within neural tissue — is increasingly recognized as a central mechanism in depression, anxiety, cognitive decline, and neurodegenerative disease, with dietary patterns modulating neuroinflammation through systemic inflammation spillover (gut-derived endotoxins crossing the blood-brain barrier), omega-6:omega-3 ratio (determining neuronal eicosanoid production), and microbiome-derived short-chain fatty acids (regulating microglial activation).
Role
Neuroinflammation as a mental health mechanism transforms diet from a peripheral lifestyle variable to a central treatment-relevant factor in psychiatric conditions — because if depression, anxiety, and cognitive decline are at least partially neuroinflammatory disorders (as mounting evidence suggests), then dietary patterns that drive or reduce systemic inflammation are directly modulating the pathophysiology of those conditions. The clinical implications of this framework are profound: dietary assessment and modification should be standard components of psychiatric treatment, not optional lifestyle advice, because the neurochemical environment being targeted pharmacologically is being simultaneously shaped by the patient's daily food choices.